NYU Langone Health - Inflammatory Bowel Disease Center (IBD) ( Site 3846) is a clinical research site located in New York, New York, United States 10016.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
NYU Langone Health - Inflammatory Bowel Disease Center (IBD) ( Site 3846) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Ulcerative Colitis.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
NYU Langone Health - Inflammatory Bowel Disease Center (IBD) ( Site 3846) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
NYU Langone Health - Inflammatory Bowel Disease Center (IBD) ( Site 3846) has 1 clinical trials on record, with 1 currently active. Their work covers Ulcerative Colitis.
NYU Langone Health - Inflammatory Bowel Disease Center (IBD) ( Site 3846) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.